Kamada (KMDA) Exchange Rate Effect (2013 - 2026)
Kamada (KMDA) posted quarterly Exchange Rate Effect of -$202000.0 for Q1 2026, down 349.38% year-on-year from $81000.0 in Q1 2025, and down 44.29% on a QoQ basis from -$140000.0 in Q4 2025.
Kamada (KMDA) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Kamada (KMDA) has reported Exchange Rate Effect for 14 consecutive years, with -$202000.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 349.38% year-over-year to -$202000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$556000.0 (down 2317.39% YoY) and the FY2025 annual result came in at -$273000.0, down 82.0% from the prior year.
- Exchange Rate Effect fell to -$202000.0 in Q1 2026 per KMDA's latest filing, from -$140000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for KMDA reached as high as $482000.0 in Q4 2023 and fell as low as -$332000.0 in Q4 2024.
- A 5-year average of $26140.7 and a median of -$296.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect surged 110910.81% — and 2024, when it tumbled 14643.59%.
- Year by year, Exchange Rate Effect stood at $112000.0 in 2022, then surged by 330.36% to $482000.0 in 2023, then slumped by 168.88% to -$332000.0 in 2024, then jumped by 57.83% to -$140000.0 in 2025, then sank by 44.29% to -$202000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$202000.0, -$140000.0, and -$61000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -202,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -202,000.00 |
| Mar 31, 2026 | -202,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Dec 31, 2025 | -140,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Sep 30, 2025 | -61,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Dec 31, 2024 | -332,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Sep 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Mar 31, 2024 | -46,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Dec 31, 2023 | 482,000.00 |